信息搜索
信息关键字：药
  

共有3954条记录

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198]

·医药ETF大跌2021-9-2 16:13:29
·世卫警告：新冠新变体“MU”或对疫苗有抗药性-财经2021-9-2 15:18:54
·康弘药业：公司及子公司使用自有资金2亿元购买理财产品2021-9-2 15:10:21
·广为医药完成新一轮融资元生创投领投2021-9-2 14:28:30
·北向资金连续8日净买入“喝酒吃药”再现20亿加仓两大行业（附股）2021-9-2 8:29:27
·普利制药实际控制人朱小平质押1530万股用于个人资金需求2021-9-1 23:23:51
·新型“超级抗体”披露，创新药企天境生物未来可期！2021-9-1 22:47:29
·睿智医药首席财务官辜团力辞职夏丹樱接任2021-9-1 21:15:17
·海辰药业股东柳晓泉质押60万股用于补充前期质押2021-9-1 19:51:16
·国家药监局：将重点加强整形用注射填充物和光治疗美容设备等产品管理2021-9-1 19:29:51
·西安怡康医药获CVC资本战略融资2021-9-1 18:35:18
·景峰医药上半年营收净利均降4成研发费用ROE齐降2021-9-1 18:31:16
·港股收评：药品股活跃朗生医药涨33.18%;重型基建股走强朝威控股涨16.67%2021-9-1 16:41:24
·医疗保健板块走低昭衍新药跌超6%2021-9-1 9:51:52
·东阳光：拟向关联方转出东阳光药不超51.41%股份2021-9-1 7:43:15
·赛隆药业：控股股东蔡南桂所持880万股解除质押2021-8-31 20:05:58
·辰星药业2021年半年度亏损243.5万元同比亏损减少36.33%2021-8-31 19:02:47
·海思科复方氨基酸(15AA-Ⅱ)/葡萄糖(10%)电解质注射液获药品注册证书|公司要闻2021-8-31 17:33:31
·昭衍新药对境内相关全资子公司增资2021-8-31 16:05:05
·恒瑞医药：子公司注射用HRS6807获得临床试验批准2021-8-31 15:56:48

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198]